This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2023 Nov 20;41(33):5203-5204.

doi: 10.1200/JCO.23.01148. Epub 2023 Sep 7.

Reply to A. Rumyantsev et al

Siamak Daneshmand¹, Brian Hu¹, Craig Nichols¹

Affiliations

Affiliation

¹ Siamak Daneshmand, MD, Department of Urology, USC/Norris Comprehensive Cancer Center, Los Angeles, CA; Brian Hu, MD, Department of Urology, Loma Linda University, Loma Linda, CA; and Craig Nichols, MD, Testicular Cancer Commons, Portland, OR.

PMID: 37677112
DOI: 10.1200/JCO.23.01148

Comment

Reply to A. Rumyantsev et al

Siamak Daneshmand et al. J Clin Oncol. 2023.

. 2023 Nov 20;41(33):5203-5204.

doi: 10.1200/JCO.23.01148. Epub 2023 Sep 7.

Authors

Siamak Daneshmand¹, Brian Hu¹, Craig Nichols¹

Affiliation

¹ Siamak Daneshmand, MD, Department of Urology, USC/Norris Comprehensive Cancer Center, Los Angeles, CA; Brian Hu, MD, Department of Urology, Loma Linda University, Loma Linda, CA; and Craig Nichols, MD, Testicular Cancer Commons, Portland, OR.

PMID: 37677112
DOI: 10.1200/JCO.23.01148

No abstract available

PubMed Disclaimer

Comment on

Surgery in Metastatic Seminoma: Negative Trial Should Be Treated as Negative.
Rumyantsev AA, Tyulyandina AS, Tryakin AA, Fedyanin MY, Tjulandin SA. Rumyantsev AA, et al. J Clin Oncol. 2023 Nov 20;41(33):5202-5203. doi: 10.1200/JCO.23.00629. Epub 2023 Sep 7. J Clin Oncol. 2023. PMID: 37677119 No abstract available.

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.